Dr. Mariana A. Kundro attended IDWeek in Atlanta, GA, USA, where she was invited to chair the oral presentation session on Tuberculosis and Other Mycobacteria. Dr. Kundro also presented the results of the study on late diagnosis of HIV infection and the experience of ChemSex users; both works from the Emerging Diseases Section of the JM Ramos Mejía Hospital were accepted as posters.
Update Seminar: Challenges and Opportunities in the Development of Clinical Research. Organized in conjunction with the Clinical Research Course of the Faculty of Medicine (UBA) and the Innovation Unit of the Hospital Italiano de Buenos Aires, Prof. Emery’s Seminar was a true privilege for those who had the opportunity to discuss new development modalities and short- and medium-term perspectives.
We welcomed Luciana Kamel, Community Representative at the HVTN, who coordinates site activities in Argentina and Brazil. Luciana visited the Emerging Diseases Research Unit and met with members of our CAB. Thank you, Luciana, for your visit and your significant contributions!
A Dra. Mariana Kundro e o Dr. Guillermo Vilora compareceram à IDWeek em Boston, onde apresentaram dados da coorte de Mpox da ClinSex e os resultados sobre as experiências de implementação da telemedicina em vários hospitais públicos de Buenos Aires.
Our project, “An Innovative Approach to Primary Care through the implementation of a Virtual Assistant for the expansion of HIV Pre-Exposure Prophylaxis,” was awarded a research grant through a competitive call by the Center for Artificial Intelligence and Health for Latin America and the Caribbean (CLIAS, https://clias.iecs.org.ar/en/about-clias), with the support of Canada’s International Development Research Centre (IDRC, https://idrc-crdi.ca/en).
In the search for answers to the current health crisis, a new Emerging Diseases Research Area was inaugurated at the JM Ramos Mejía Hospital, in conjunction with the Ibis Foundation. This new area was made possible through a research grant from the US National Institutes of Health (NIH) HVTN network. The JM Ramos Mejía Hospital has a long tradition of high-quality clinical research, and its researchers have contributed over the years with results of great importance to public health. It is the only public hospital in the country, and one of the few in Latin America, that participates in these academic research networks. This Emerging Diseases Research Area is part of the Immunocompromised Service of the J. M. Ramos Mejía General Acute Hospital and is directed by its Head, Doctor Marcelo H. Losso. https://www.youtube.com/watch?v=XkXGzN-dpeA
